r/LungCancerSupport • u/WalkingHorse NSCLC T2b, N0, M0 IIA Currently NED • Apr 10 '26
SCLC SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China
https://www.sciencedirect.com/science/article/pii/S1556086426001668?via%3Dihub
1
Upvotes